-logo-1200x675.png?v=20240417094222&w=240&h=240&zc=2){kind=logo}
HC Wainwright Lowers Y-mAbs Therapeutics (NASDAQ:YMAB) Price Target to $11.00
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) had its price objective dropped by investment analysts at HC Wainwright from $12.00 to $11.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s target price points to a potential upside of 160.05% […]
Y-mAbs Therapeutics (NASDAQ:YMAB – Get Free Report) had its price objective dropped by investment analysts at HC Wainwright from $12.00 to $11.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. HC Wainwright’s target price points to a potential upside of 160.05% […]
